Mojtaba Sankian
Overview
Explore the profile of Mojtaba Sankian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
1071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jomehpour N, Sankian M, Soleimanpour S, Derakhshan M, Ghazvini K, Pordel S, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2025 Mar;
43(3):148-155.
PMID: 40037743
Introduction: Gold nanoparticles (GNPs) are chemically inert, have low toxicity, and are easy to modify and functionalize for the detection of many pathogens. They have excellent immune modulatory and adjuvant...
2.
Dangkoub F, Bemani Naeini M, Akar S, Badiee A, Jaafari M, Sankian M, et al.
Int J Pharm X
. 2024 Dec;
8:100309.
PMID: 39697814
Development of techniques to produce nanoformulations in a controlled and reproducible manner is of great importance for research, clinical trials, and industrial scale-up. This research aimed to introduce a cost-effective...
3.
Izadi N, Sankian M, Meshkat Z, Aryan E
Gene
. 2024 Dec;
938:149163.
PMID: 39675396
No abstract available.
4.
Amini Y, Kabiri M, Jamehdar S, Sankian M, Meshkat Z, Zare S, et al.
J Pharm Sci
. 2024 Dec;
114(2):1133-1141.
PMID: 39631524
The antigen-targeting to dendritic cells (DCs) has gained increasing attention as the potential approach for immunotherapy in recent years due to the ability of DCs to regulate innate and adaptive...
5.
Haghnavaz N, Rezaee M, Pordel S, Shobeiri S, Dashti M, Ansari B, et al.
Immunopharmacol Immunotoxicol
. 2024 Oct;
46(6):815-828.
PMID: 39376102
Objective: One of the most effective treatments for allergic respiratory diseases is allergen-specific sublingual immunotherapy (SLIT). While, mannose targeting has been applied in various immunostimulatory approaches, but it has not...
6.
Asaadi H, Vojdani A, Meshkat Z, Sankian M, Farsiani H, Tavakoly Sany S, et al.
Talanta
. 2024 Aug;
280:126706.
PMID: 39153257
In this study, a porous carbon derived from a metal-organic framework (PCMOF) as a target-responsive material functionalized with Nocardia particular antisense ssDNA oligonucleotide (ssDNA capture probe) was developed to construct...
7.
Emami Z, Shobeiri S, Khorrami R, Haghnavaz N, Rezaee M, Moghadam M, et al.
Mediators Inflamm
. 2024 Jul;
2024:5821996.
PMID: 39045230
Background: Psoriasis is a noncontagious auto-inflammatory chronic skin disease. So far, some of the inflammatory genes were upregulated in mouse model of psoriasis. This study examined changes in skin mRNA...
8.
Rezaee M, Shobeiri S, Moghadam M, Mashayekhi K, Sankian M
J Pharm Biomed Anal
. 2024 May;
247:116245.
PMID: 38810331
Interleukin (IL)-23 inhibitor monoclonal antibodies shown significant efficacy in treating autoimmune diseases. DNA or RNA aptamers exhibit comparable specificity to antibodies, are cost-effective, non-immunogenic, and do not have batch to...
9.
Ansari B, Abbaspour M, Estajy A, Haghnavaz N, Pordel S, Rezaee M, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 May;
397(10):7839-7856.
PMID: 38743115
Curcumin (CUR) has been considered a potential therapeutic agent for allergic reactions due to its antioxidant and anti-inflammatory activities. Nanofibers have attracted increasing attention in drug delivery. The aim of...
10.
Karbalaei M, Mosavat A, Soleimanpour S, Farsiani H, Ghazvini K, Amini A, et al.
Curr Microbiol
. 2024 Apr;
81(5):127.
PMID: 38575759
An urgent need is to introduce an effective vaccine against Mycobacterium tuberculosis (M.tb) infection. In the present study, a multi-stage M.tb immunodominant Fcγ1 fusion protein (Ag85B:HspX:hFcγ1) was designed and produced,...